TY  - GEN
AU  - Ellis,C N
AU  - Varani,J
AU  - Fisher,G J
AU  - Zeigler,M E
AU  - Pershadsingh,H A
AU  - Benson,S C
AU  - Chi,Y
AU  - Kurtz,T W
TI  - Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation
SN  - 0003-987X
PY  - 2000///0530
KW  - Adult
KW  - Animals
KW  - Antineoplastic Agents
KW  - metabolism
KW  - Cell Differentiation
KW  - Chromans
KW  - DNA Primers
KW  - Female
KW  - Humans
KW  - Keratinocytes
KW  - cytology
KW  - Ligands
KW  - Male
KW  - Mice
KW  - Mice, SCID
KW  - Psoriasis
KW  - drug therapy
KW  - RNA, Messenger
KW  - Receptors, Cytoplasmic and Nuclear
KW  - genetics
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Skin Diseases
KW  - Thiazoles
KW  - Thiazolidinediones
KW  - Transcription Factors
KW  - Troglitazone
N1  - Publication Type: Case Reports; Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1001/archderm.136.5.609
ER  -